Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Cancer Chemotherapy and Pharmacology|January 29, 1999
Epirubicin-containing high-dose chemotherapy followed by autologous hematopoietic progenitor cell transfusion for patients with chemotherapy-sensitive metastatic breast cancer: results of 5-year follow-upY Ito, T Mukaiyama, M Ogawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1990
[High-dose cyclophosphamide, thio-TEPA, etoposide with autologous bone marrow transplantation for refractory cancers]T Mukaiyama, M Ogawa, N Horikoshi, et al.
Physical Review Letters|March 24, 2005
Coherent molecular optics using ultracold sodium dimersJ R Abo-Shaeer, D E Miller, J K Chin, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1986
[Choice of second-line chemotherapy for advanced breast cancer based on the chemosensitivity assay by in vitro colony assay]K Inoue, T Mukaiyama, H Yamazaki, et al.
Physical Review Letters|December 20, 2003
Formation of quantum-degenerate sodium moleculesK Xu, T Mukaiyama, J R Abo-Shaeer, et al.
Journal of Hematotherapy|January 1, 1994
Isolation of human CD34+ peripheral blood stem cells using an immunomagnetic positive selection system: prior monocyte depletion using a nylon-wool columnY Nakamura, M Noma, M Kidokoro, et al.
Archives of Histology and Cytology|October 1, 1990
Immunohistochemical evidence of the extracellular localization of calcium-activated neutral protease (CANP) in rabbit skeletal muscle, lung and aortaE Adachi, T Mukaiyama, K Sasai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1988
[Phase II study of combination chemotherapy with epirubicin, cyclophosphamide and ftorafur in metastatic breast cancer]K Shinagawa, M Ogawa, N Horikoshi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1989
[A study to overcome drug resistance using high-dose chemotherapy with autologous bone marrow transplantation]T Mukaiyama, M Ogawa, N Horikoshi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1989
[4'-(9-acridinylamino)-methanesulfon-m-aniside (AMSA) combination salvage therapy in refractory acute non-lymphocytic leukemia in adults]T Mukaiyama, M Ogawa, N Horikoshi, et al.
Pageof 7